Xinfengming Group Co., Ltd. (SHSE:603225) Just Released Its Annual Results And Analysts Are Updating Their Estimates
Xinfengming Group Co., Ltd. (SHSE:603225) Just Released Its Annual Results And Analysts Are Updating Their Estimates
Last week, you might have seen that Xinfengming Group Co., Ltd. (SHSE:603225) released its yearly result to the market. The early response was not positive, with shares down 2.4% to CN¥13.93 in the past week. Results overall were respectable, with statutory earnings of CN¥0.72 per share roughly in line with what the analysts had forecast. Revenues of CN¥61b came in 2.7% ahead of analyst predictions. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.
上週,你可能已經看到新豐明集團有限公司(SHSE: 603225)向市場發佈了年度業績。早期的反應並不樂觀,過去一週股價下跌2.4%,至13.93元人民幣。總體業績不錯,每股0.72元人民幣的法定收益與分析師的預測大致一致。610億元人民幣的收入比分析師的預測高出2.7%。對於投資者來說,這是一個重要時刻,因爲他們可以在報告中追蹤公司的業績,看看專家對明年的預測,看看對該業務的預期是否有任何變化。考慮到這一點,我們收集了最新的法定預測,以了解分析師對明年的預期。
Taking into account the latest results, the most recent consensus for Xinfengming Group from nine analysts is for revenues of CN¥65.9b in 2024. If met, it would imply a satisfactory 7.2% increase on its revenue over the past 12 months. Per-share earnings are expected to leap 66% to CN¥1.19. Before this earnings report, the analysts had been forecasting revenues of CN¥64.9b and earnings per share (EPS) of CN¥1.22 in 2024. The analysts seem to have become a little more negative on the business after the latest results, given the minor downgrade to their earnings per share numbers for next year.
考慮到最新業績,九位分析師對新豐明集團的最新共識是,2024年的收入爲659億元人民幣。如果得到滿足,這意味着其收入在過去12個月中增長了令人滿意的7.2%。每股收益預計將增長66%,至1.19元人民幣。在本業績發佈之前,分析師一直預測2024年的收入爲649億元人民幣,每股收益(EPS)爲1.22元人民幣。鑑於明年的每股收益數據略有下調,分析師在最新業績公佈後似乎對該業務變得更加負面了。
The consensus price target held steady at CN¥14.00, with the analysts seemingly voting that their lower forecast earnings are not expected to lead to a lower stock price in the foreseeable future. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Xinfengming Group, with the most bullish analyst valuing it at CN¥15.40 and the most bearish at CN¥12.60 per share. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Xinfengming Group is an easy business to forecast or the the analysts are all using similar assumptions.
共識目標股價穩定在14.00元人民幣,分析師似乎投票認爲,在可預見的將來,他們較低的預期收益預計不會導致股價下跌。但是,這並不是我們可以從這些數據中得出的唯一結論,因爲一些投資者在評估分析師目標股價時也喜歡考慮估計值的差異。對新豐銘集團的看法各不相同,最看漲的分析師將其估值爲15.40元人民幣,最看跌的爲每股12.60元人民幣。即便如此,在估計分組相對接近的情況下,分析師似乎對自己的估值非常有信心,這表明新豐明集團是一家易於預測的企業,或者分析師都使用了類似的假設。
These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Xinfengming Group's past performance and to peers in the same industry. It's pretty clear that there is an expectation that Xinfengming Group's revenue growth will slow down substantially, with revenues to the end of 2024 expected to display 7.2% growth on an annualised basis. This is compared to a historical growth rate of 13% over the past five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 17% per year. Factoring in the forecast slowdown in growth, it seems obvious that Xinfengming Group is also expected to grow slower than other industry participants.
這些估計很有趣,但是在查看預測與新豐明集團過去的表現以及與同一行業的同行進行比較時,可以更粗略地描述一些細節。很明顯,預計新豐明集團的收入增長將大幅放緩,預計到2024年底的收入按年計算將增長7.2%。相比之下,過去五年的歷史增長率爲13%。相比之下,該行業中其他有分析師報道的公司的收入預計將以每年17%的速度增長。考慮到增長放緩的預測,很明顯,預計新豐明集團的增長速度也將低於其他行業參與者。
The Bottom Line
底線
The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Xinfengming Group. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Xinfengming Group's revenue is expected to perform worse than the wider industry. The consensus price target held steady at CN¥14.00, with the latest estimates not enough to have an impact on their price targets.
最大的擔憂是,分析師下調了每股收益預期,這表明新豐明集團可能會面臨業務不利因素。幸運的是,分析師還重申了他們的收入預期,表明收入符合預期。儘管我們的數據確實表明,預計新豐明集團的收入表現將比整個行業差。共識目標股價穩定在14.00元人民幣,最新估計不足以對其目標價格產生影響。
Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple Xinfengming Group analysts - going out to 2026, and you can see them free on our platform here.
考慮到這一點,我們仍然認爲該業務的長期發展軌跡對於投資者來說更爲重要。根據信豐明集團多位分析師的估計,預計將持續到2026年,你可以在我們的平台上免費查看。
Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Xinfengming Group that you should be aware of.
別忘了可能仍然存在風險。例如,我們已經確定了新豐明集團的1個警告標誌,你應該注意這一點。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。